Answers are grounded in this paper and cite their sources.
Our study is the first to comprehensively track dynamic changes in cerebrospinal fluid (CSF) aquaporin-4 (AQP4) levels in patients with moderate to severe traumatic brain injury. We show that AQP4 peaks at 14 days, correlates with injury severity, and consistently predicts 3-mo outcomes, with the strongest prognostic accuracy at day 14. These findings identify CSF AQP4 as a promising biomarker for assessing severity and prognosis, offering potential to improve early prediction and guide clinical decision-making in TBI management.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: